Author:
Lékó András H.,Farokhnia Mehdi,Leggio Lorenzo
Publisher
Springer International Publishing
Reference169 articles.
1. Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA. 2018;320(8):815–24.
2. US Food and Drug Administration. Alcoholism: developing drugs for treatment guidance for industry: draft guidance. FDA; 2015. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/alcoholism-developing-drugs-treatment.
3. European Medicines Agency. Guideline on the development of medicinal products for the treatment of alcohol dependence. London: EMA; 2010. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-development-medicinal-products-treatment-alcohol-dependence_en.pdf.
4. Falk DE, O’Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, et al. Evaluation of drinking risk levels as outcomes in alcohol pharmacotherapy trials: a secondary analysis of 3 randomized clinical trials. JAMA Psychiatry. 2019;76(4):374–81.
5. Lohoff FW. Pharmacotherapies and personalized medicine for alcohol use disorder: a review. Pharmacogenomics. 2020;21(15):1117–38.